Coronavirus hits every resident of Kansas nursing home, linked to 10 deaths All 62 residents tested positive for the novel coronavirus, resulting in at least 10 deaths.
Women take coronavirus more seriously than men, study shows Coronavirus precautions are now apparently in the same league as stopping to ask for directions and taking more than one trip to carry stuff.
Pregnancy warning extended for common pain relievers, FDA says The FDA said taking these common pain relievers at 20 weeks gestation or later in the pregnancy can cause rare but serious kidney problems in the unborn baby, leading to low levels of amniotic fluid and possible pregnancy-related complications.
Regeneron's Ebola drug gets first-ever FDA approval The Food and Drug Administration (FDA) announced the first-ever approval of an Ebola drug, which is made of three monoclonal antibodies.
Vaping lands Florida teen in the hospital, parents say Vaping is reportedly behind a Florida teen’s recent hospitalization, according to a local report.
Coronavirus complication prompts heart transplant in previously healthy teen, doctor says One doctor recently worked to dispel the idea that COVID-19 illness does not affect children, as he described one severe case involving a heart transplant.
Cottonelle flushable wipes recalled over bacteria concerns Cottonelle Flushable Wipes are facing a recall over concerns they have been contaminated with bacteria.
Ex-patients of UCLA gynecologist accused of sexually assaulting them are ‘voice for so many,’ lawyers say Heaps is accused of preying on dozens of patients, including women who had been recently diagnosed with cancer or were even suffering from cognitive issues.
Flu vaccine in kids reduces risk of related hospitalizations, study finds A new study found that last year's vaccine, which was estimated to be between 40% and 60% effective, actually reduced pediatric flu-related emergency room visits by as much as 51%.
Rheumatoid arthritis drug cuts coronavirus deaths in clinical trial, Eli Lilly says In the clinical trial patients are given a combination of baricitinib and remdesivir.
